Investments in progress and portfolio companies

Learn about the companies developing tomorrow’s diagnostics, therapeutics and healthcare

Investments in progress​

Learn more about our ongoing investments. We have made our analysis, negotiated the terms and made our decision. We have compiled the information and documents for you to make your decision.

PeptiSystems AB

PeptiSystems has developed a groundbreaking technology for the large-scale production of precision drugs. The company sells instruments for manufacturing peptides and oligonucleotides used in pharmaceutical manufacturing.

Read more

Investments in progress​

We are currently investing in one or more companies that passed our rigorous selection process. Please login or create an account to learn more and co-invest with us.

Our portfolio companies

Our portfolio companies are currently developing diagnostics for early detection of cancer via blood sample, saving lives in emergency care and surgery through software innovations, developing personalised treatments of severe diseases, and much more.

Predicare

Predicare is the company behind the system RETTS©, used by 95% of Sweden’s hospitals and ambulances. RETTS© daily helps healthcare professionals to make the right decisions in emergency situations.

Read more

Elypta

Elypta has developed a new method for early cancer diagnosis. Liquid Biopsy is a rapidly growing field that is expected to be of great importance for cancer diagnosis.

Read more

Single Technologies

The company has developed a DNA sequencing solution with significantly improved performance compared with current alternatives. The market is growing rapidly in terms of both research and clinical applications.

Read more
Load More

Exits

Former portfolio companies that have reached new heights through acquisition or listing, and continue to thrive under new ownership. These companies continue to make a lasting impact in their respective industries.